Weil Company’s Teladoc Health TDOC Stock Holding History

Weil Company’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-27	Closed	-$2K	–	301
2019 Q3	$2K	Buy	+27	New	+$1.78K	﹤0.01%	366

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Weil Company's TDOC Position: Q4 2019 in Review

Weil Company sold out of Teladoc Health (TDOC) in Q4 2019, closing a stake of 27 shares — an estimated $2K sold.

Weil Company first reported a position in TDOC in Q3 2019 and held it in 1 quarter. The position peaked at $2K in Q3 2019. 421 funds tracked by Wall St. Rank hold TDOC as of Q4 2019.

Weil Company reported no remaining Teladoc Health position as of Q4 2019 after selling out during the quarter.
Weil Company sold 27 Teladoc Health shares in Q4 2019, an estimated $2K.
Weil Company first reported a position in Teladoc Health in Q3 2019 and held it in 1 quarter.
Weil Company's Teladoc Health position peaked at $2K in Q3 2019.
421 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.